Healthcare

ECS Botanics Holdings Ltd (ASX:ECS)

Industry Group : Pharmaceuticals, Biotechnology & Life Sciences | Industry Group Name : Pharmaceuticals

Market Price : AUD 0.0370 (0%)

(as on 2021-10-24 00:50:26)

Market Cap : AUD 33.549 M

Previous Close Open Close* Day Range 52 WEEK HIGH LOW
0.037 0.039 0.037 0.037L 0.039 H 0.0240272109L 0.0780884354 H
Last Trade 0.037
Change% 0.0000
52 W H/L 0.0780884354/0.0240272109
EBITDA -4.757 M
NPAT After Abnormal Items -4.336 M
Equity 17.09 M
ROE% -25.37%
Total Liabilities 1.416 M
Total Revenue 1.803 M
Cash and Cash Equivalents 4.245 M

Stock Information

Share price 0.037
Market Cap 33.549 M
Price/Gross Cash Flow -9.20
Dividend Yield Excluding Special 0.00%
Ending Shares 862.981 M
52-Week Range 0.0240272109-0.0780884354
P/E ratio 0.000
Sector P/E --
EPS -0.64
EV/EBITDA --
Net Profit Margin (%) -347.79%
Gross Cash Flows Per Share -0.01
Net Gearing -24.68%
Gross DPS (AUD) 0
Gross Dividend Yield (Annualized) 0.00%
Earnings Yield 0.000
Net Tangible Asset (NTA) 0.02
Sales Per Share 0.00
Book Value Per Share 0.02

Announcements

Heading Date/Time
Results of Annual General Meeting  22/10/2021 1:55PM
Quarterly Activities/Appendix 4C Cash Flow Report  22/10/2021 9:44AM
ECS to achieve record quarterly revenue  08/10/2021 9:38AM
Notice of Annual General Meeting/Proxy Form  20/09/2021 5:48PM
World class advisory board established  20/09/2021 9:36AM
Change of Director's Interest Notice (x2)  10/09/2021 9:57AM
Vesting of Milestone A Performance Rights  08/09/2021 6:59PM
Secondary Trading Notice  08/09/2021 6:53PM
Application for quotation of securities - ECS  08/09/2021 6:51PM
ECS secures supply agreement with Canngea  08/09/2021 8:52AM
Investor Presentation  02/09/2021 9:49AM
Appendix 4G and Corporate Governance Statement  31/08/2021 3:22PM
Appendix 4E & Annual Report  31/08/2021 3:18PM
ECS secures $1.75m supply agreement into New Zealand  30/08/2021 8:52AM
AGM Date and Closing Date for Director Nominations  27/08/2021 3:59PM
Coles to stock ECS Hemp Seed Oil  16/08/2021 9:17AM
Change of Director's Interest Notice  09/08/2021 8:49AM
Quarterly Activities/Appendix 4C Cash Flow Report  28/07/2021 8:52AM
ECS secures $4.5m supply agreement into Europe  26/07/2021 8:51AM
Restricted Securities Released from Escrow  23/07/2021 8:22AM
Application for quotation of securities - ECS  23/07/2021 8:22AM
Change in substantial holding  09/07/2021 8:42AM
ECS appoints four industry leaders to support growth  02/07/2021 8:34AM
Secondary Trading Notice  30/06/2021 7:12PM
Application for quotation of securities - ECS  30/06/2021 7:12PM
Release from Escrow - 22 July 2021  18/06/2021 8:19AM
Strong sales growth following first commercial harvest  09/06/2021 8:48AM
ECS launches Innovative range of 30ml Terpene Blends  20/05/2021 9:56AM
Quarterly Activities Report and Appendix 4C  29/04/2021 8:44AM

Similar Companies

Related Articles

Load More

About Company

ECS Botanics Holdings Ltd (ASX: ECS) is one of the largest players in the Australian hemp market. The company boasts a specialised supply chain, in addition to a best of breed farmer network. Its range of products include hemp oil capsules, hemp hearts, hemp oil and hemp protein, in addition to other hemp-based products. ECS is focused on retail as well as wholesale hemp food products.

Corporate Information

company address Suite 2, Level 1, 1 Altona Street, WEST PERTH, WA, AUSTRALIA, 6005

company phone08 6559 -1792

company websitehttps://ecsbotanics.com.au

Dividends

Ex-Dividend Date Franking DPS (AUD) Dividend Yield
30/06/2021 -- 0.000 0.00%
30/06/2020 -- 0.000 0.00%
30/06/2019 -- 0.000 0.00%
30/06/2018 -- 0.000 0.00%
30/06/2017 -- 0.000 0.00%
30/06/2016 -- 0.000 0.00%
30/06/2015 -- 0.000 0.00%
30/06/2014 -- 0.000 0.00%
30/06/2013 -- 0.000 0.00%
30/06/2012 -- 0.000 0.00%

Event Calendar

Event Type Event Date Event Year
Report (Annual) 2022-08-30 2022
Report (Prelim) 2022-08-30 2022
Report (Interim) 2022-02-22 2022

Financials

Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Trading Revenue 1.247 M 836,760 -- -- --
Other Revenue 556,821 82,368 0 0 0
Total Revenue 1.803 M 919,128 0 0 0
Interest Income 875 0 1,384 21,643 348
Interest Expenses 0 0 0 0 0
Expenses -6.706 M -5.466 M -568,500 -240,355 -263,896
EBITDA -4.902 M -4.547 M -568,500 -240,355 -263,896
Depreciation and Amortization -187,926 -22,378 0 0 0
Depreciation -96,843 -22,378 0 0 0
Amortisation -91,083 0 0 0 0
EBIT -5.09 M -4.569 M -568,500 -240,355 -263,896
Pre Tax Profit -5.089 M -4.569 M -567,116 -218,712 -263,548
Tax Expense 753,710 0 0 0 0
Net Profit After Tax -4.336 M -4.569 M -567,116 -218,712 -263,548
Minority Interest 0 0 0 0 0
Preference Dividend 0 0 0 0 0
Net Abnormal Items 0 0 0 0 0
Reported Net Profit After Abnormal Items -4.336 M -4.569 M -567,116 -218,712 -263,548
Ending Shares 862.981 M 507.591 M 47.591 M 38.937 M 38.937 M
Weighted Average Shares 676.354 M 507.591 M 41.276 M 38.937 M 26.919 M
EPS After Abnormal Items (cents) -0.64 -0.9 -1.37 -0.56 -0.98
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Total Current Assets 8.044 M 3.328 M 7.115 M 212,717 424,277
Total Non Current Assets 10.462 M 2.139 M 0 0 0
Total Assets 18.506 M 5.467 M 7.115 M 212,717 424,277
Total Current Liabilities 1.398 M 432,036 7.243 M 24,233 17,081
Total Non Current Liabilities 18,154 0 0 0 0
Total Liabilities 1.416 M 432,036 7.243 M 24,233 17,081
Net Assets 17.09 M 5.035 M -127,847 188,484 407,196
Breakdown 30/06/2021 30/06/2020 30/06/2019 30/06/2018 30/06/2017
Net Operating Cash -2.264 M -2.926 M -386,539 -216,963 -283,846
Net Invested Cash -4.596 M -2.204 M 0 0 0
Net Financing Cash Flows 9.201 M 6.071 M 6.581 M 0 351,000
Beginning Cash 1.904 M 962,808 205,045 422,008 354,854
End Cash Position 4.245 M 1.904 M 6.399 M 205,045 422,008
Exchange Rate Adjustments 0 0 0 0 0
Other Cash Adjustments 0 0 0 0 0
Ending Cash 4.245 M 1.904 M 6.399 M 205,045 422,008

© Morningstar, Inc. 2021. All rights reserved. Neither Morningstar, its affiliates, nor the content providers guarantee the market indices, commodities and regulatory news headlines, and other data or content contained herein to be accurate, complete, or timely, and nor shall they have any liability for its use or distribution. The data contained herein: (1) is proprietary to Morningstar and/or its affiliates (collectively, “Morningstar”) and/or their content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete, or timely. Our publications, ratings and products should be viewed as an additional investment resource, and not as your sole source of information. Past performance does not necessarily indicate a financial product’s future performance. To obtain advice tailored to your financial situation, contact a professional financial adviser. Some material is copyrighted and published under licence from ASX Operations Pty. Ltd. ACN 004523782.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK